Boston Scientific (BSX) is down 35% but still growing fast with strong margins—see valuation, key catalysts (WATCHMAN, EP, M&A), and risks.
LIVE
--
--
--
--
--
--
--
--
Official App
Download world's #1 News App
Get real-time alerts on your phone
